CN116139042A - Hair treatment composition - Google Patents
Hair treatment composition Download PDFInfo
- Publication number
- CN116139042A CN116139042A CN202310184387.XA CN202310184387A CN116139042A CN 116139042 A CN116139042 A CN 116139042A CN 202310184387 A CN202310184387 A CN 202310184387A CN 116139042 A CN116139042 A CN 116139042A
- Authority
- CN
- China
- Prior art keywords
- phase
- hair
- surfactant
- cationic polymer
- different
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 239000004094 surface-active agent Substances 0.000 claims abstract description 72
- 229920006317 cationic polymer Polymers 0.000 claims abstract description 68
- 230000003750 conditioning effect Effects 0.000 claims abstract description 27
- 230000008021 deposition Effects 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 13
- 238000004140 cleaning Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 230000003752 improving hair Effects 0.000 claims description 3
- 238000009825 accumulation Methods 0.000 description 14
- 229920002545 silicone oil Polymers 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000002453 shampoo Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- -1 polyoxyethylene Polymers 0.000 description 4
- 230000008719 thickening Effects 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- KTYVHLCLTPLSGC-UHFFFAOYSA-N amino propanoate Chemical compound CCC(=O)ON KTYVHLCLTPLSGC-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- SAGXGPWVLUSDSQ-RVZXSAGBSA-N (2r)-2-amino-3-(carboxymethylsulfanyl)propanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CSCC(O)=O SAGXGPWVLUSDSQ-RVZXSAGBSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940071124 cocoyl glutamate Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 229940079779 disodium cocoyl glutamate Drugs 0.000 description 1
- QIVLQXGSQSFTIF-UHFFFAOYSA-M docosyl(trimethyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C QIVLQXGSQSFTIF-UHFFFAOYSA-M 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000003741 hair volume Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 1
- 229940048848 lauryl glucoside Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WYTNTFGZBBTWNR-UHFFFAOYSA-M methyl sulfate;trimethyl(octadecyl)azanium Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCC[N+](C)(C)C WYTNTFGZBBTWNR-UHFFFAOYSA-M 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 description 1
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229940079988 potassium cocoyl glycinate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229940024463 silicone emollient and protective product Drugs 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229940031688 sodium c14-16 olefin sulfonate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940065859 sodium cocoyl glycinate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
Abstract
The present application discloses a hair treatment composition comprising a phase a and a phase B which are non-mixed or non-homogeneously mixed two phases which are effective in solving the problem of "conditioning build-up" by having the phase a and the phase B comprise at least one different surfactant and at least one different cationic polymer.
Description
Technical Field
The present application relates to the field of cosmetic technology, and in particular to a hair treatment composition.
Background
The shampoo with two functions of washing and protecting is needed to realize two functions in the shampoo process: (1) cleaning function: emulsifying greasy dirt and particulate matters on hair and scalp by using surfactant in the formula, so that the greasy dirt is washed away along with water flow; (2) conditioning function: a certain amount of conditioning agent is deposited on the hair, so that the hair scales of the hair are closed, and the hair is smooth, easy to comb and glossy after being washed.
However, one of the pain points of the two-in-one shampoo is conditioning accumulation, namely, after the shampoo is used for many times, the conditioner can be accumulated on the hair continuously, so that the hair becomes sticky and flat.
In the prior art, some manufacturers adopt a formula of an ultralow-content conditioner to slow down conditioning accumulation speed, but the method for reducing the using amount of the conditioner simultaneously brings about weakening of conditioning functions of the shampoo and hair frizziness and the like; shampoo manufacturers have also employed specialty silicone oil materials, such as that disclosed in patent CN105636650a, a hair care composition comprising viscoelastic particles to minimize the excipient materials responsible for sagging and hair volume reduction by allowing the pocket to exhibit specific storage modulus and loss modulus values, however, specialty materials are more limited in availability and increase in cost of use.
Disclosure of Invention
In view of the above technical problems, the present application provides a hair treatment composition comprising a phase a and a phase B, which are non-mixed or non-uniformly mixed two phases, which can effectively solve the problem of "conditioning accumulation" by allowing at least one different surfactant and at least one different cationic polymer to be present in the a phase and the B phase.
The specific technical scheme of the application is as follows:
1. a hair treatment composition comprising a phase a and a phase B, both containing a surfactant and a cationic polymer, the a and B phases being non-mixed or non-homogeneously mixed two phases;
the phase A and the phase B contain at least one different surfactant;
the phase a and the phase B contain at least one different cationic polymer.
2. The hair treatment composition according to item 1, wherein the mass ratio between the different surfactants present in the a-phase and B-phase is from 3:1 to 1:3.
3. The hair treatment composition according to item 1 or 2, wherein the mass ratio of the different cationic polymers present in the a-phase and B-phase is from 3:2 to 1:2.
4. The hair treatment composition according to any one of claims 1 to 3, wherein,
the mass percentage of the surfactant in the phase A is 8-20%;
the mass percentage of the surfactant in the phase B is 8-20%.
5. The hair treatment composition according to any one of claims 1 to 4, wherein,
the cationic polymer in the A phase is 0.15-0.75% of the cationic polymer in the B phase;
the cationic polymer in the B phase is 0.15-0.75% of the cationic polymer in the A phase.
6. Use of the hair treatment composition according to any one of claims 1 to 5 for cleaning and caring hair.
7. Use according to item 6, for improving the deposition rate of conditioning agents on hair.
8. Use according to item 6 or 7, of the hair treatment composition for improving hair shine and/or collapse.
9.A method of using the hair treatment composition of any of claims 1-5, comprising:
applying phase a and phase B of said hair treatment composition to hair;
washing the phase a and phase B on the hair.
Use of a phase a composition and a phase B composition in combination in hair treatment, both of the phase a composition and the phase B composition comprising a surfactant and a cationic polymer;
the phase A composition and the phase B composition contain at least one different surfactant;
the phase A composition and the phase B composition contain at least one different cationic polymer.
11. The use according to item 10, wherein the a-phase and B-phase compositions are the a-phases and B-phases referred to in any one of items 2 to 5.
ADVANTAGEOUS EFFECTS OF INVENTION
The hair treatment composition can effectively solve the problem of excessive accumulation of the conditioning agent in the existing hair cleaning products, and improves the bad effects of sticky and flat hair caused by excessive accumulation of the conditioning agent.
Detailed Description
The present application is described in detail below in connection with the described embodiments. While specific embodiments of the present application are shown, it should be understood that the present application may be embodied in various forms and should not be limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the disclosure to those skilled in the art.
It should be noted that certain terms are used throughout the description and claims to refer to particular components. Those of skill in the art will understand that a person may refer to the same component by different names. The specification and claims do not identify differences in terms of components, but rather differences in terms of the functionality of the components. As referred to throughout the specification and claims, the terms "include" or "comprising" are used in an open-ended fashion, and thus should be interpreted to mean "include, but not limited to. The description hereinafter sets forth the preferred embodiment for carrying out the present application, but is not intended to limit the scope of the present application in general, as the description proceeds. The scope of the present application is defined by the appended claims.
In this application, the term "conditioning accumulation" refers to the continuous accumulation of conditioning agents on hair, which makes the hair become sticky, flat, etc., and the problem of "conditioning accumulation" can be effectively solved by using the composition described in this application.
In this application, the method of measuring "conditioning accumulation" is not limited in any way, and a conventional method may be selected as required, for example, a test may be performed using a real human hair strand, and the deposition rate of the cationic polymer may be calculated by measuring the mass increment of the hair strand. For example, the deposition rate of cationic polymer can be calculated by subjecting the hair strands to 2 and 6 wash cycles, and measuring the mass increase of the hair strands.
The present application provides a hair treatment composition comprising a phase a and a phase B, both of which contain a surfactant and a cationic polymer, the a phase and the B phase being non-mixed or non-homogeneously mixed two phases;
the phase A and the phase B contain at least one different surfactant;
the phase a and the phase B contain at least one different cationic polymer.
In the present application, the type of the surfactant contained in each phase is not limited at all, and may be any type of surfactant, for example, an anionic surfactant, a cationic surfactant, a nonionic surfactant, an amphoteric surfactant, or the like.
In the present application, the anionic surfactant includes, but is not limited to, sulfonate, sulfate, cholate, etc., and may be, for example, sodium laurylsulfate, ammonium laurylsulfate, sodium C14-16 olefin sulfonate, sodium lauroyl sarcosinate, potassium cocoyl glycinate, sodium cocoyl aminopropionate, disodium cocoyl glutamate, sodium cocoyl glycinate, sodium methyl cocoyl taurate, etc., cleaning products, and anionic surfactants commonly used in the cosmetic field.
In this application, the cationic surfactants include, but are not limited to, behenyl trimethyl ammonium chloride, behenyl trimethyl ammonium methyl sulfate, stearyl trimethyl ammonium chloride, stearyl trimethyl ammonium methyl sulfate, stearamidopropyl dimethylamine and like cleaning products and cationic surfactants commonly used in the cosmetic arts.
In this application, the nonionic surfactant may be classified into polyoxyethylene type, polyol type, alkanolamide type, polyether type, amine oxide type, and the like according to the structure of the hydrophilic group. Further, the nonionic surfactants include, but are not limited to, lauryl glucoside, decyl glucoside, coco amide methyl MEA, coco amide DEA, coco amide MEA, and other cleaning products and nonionic surfactants commonly used in the cosmetic field.
In the present application, the amphoteric surfactant includes, but is not limited to, amino acid type, betaine type, and may be, for example, cleaning products such as lauroyl amino acid salt, cocoyl glutamate, cocoamidopropyl betaine, sodium cocoyl aminopropionate, and the like, and amphoteric surfactants commonly used in the cosmetic field.
In the present application, the type of the cationic polymer is not limited, and it may be any cationic polymer commonly used in the art, for example, the cationic polymer may be selected from the group consisting of polyquaternium and cationic guar gum, for example, polyquaternium-7, polyquaternium-10, guar hydroxypropyl trimethylammonium chloride, hydroxypropyl guar hydroxypropyl trimethylammonium chloride, and the like, but may be any one as long as the a phase and the B phase contain at least one different cationic polymer.
In the compositions described herein, the a phase and the B phase are non-mixed or non-uniformly mixed two phases, and therefore, when the composition is applied to hair, the a phase and the B phase exhibit a non-uniformly mixed state, which is advantageous for improving the deposition rate of the conditioning agent on the hair, so that the problem of "conditioning accumulation" can be solved, i.e., the "conditioning accumulation" can be effectively reduced.
In some embodiments, the mass ratio between the different surfactants present in the a-phase and the B-phase is from 3:1 to 1:3.
For example, the mass ratio between the different surfactants present in the a and B phases may be 3:1, 2:1, 1:1, 1:2, 1:3, etc.
In some embodiments, the mass ratio of the different cationic polymers present in the a phase and the B phase is from 3:2 to 1:2.
For example, the mass ratio of the different cationic polymers present in the A and B phases may be 3:2, 1:0.8, 1:1, 1:1.5, 1:2, etc.
In some embodiments, the surfactant in the a phase is 8-20% by mass of the a phase, specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, etc.; the surfactant in the B phase accounts for 8-20% by mass, and specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20% by mass, etc.
In some embodiments, the surfactant content in the a phase or the B phase may be the same or different in terms of mass percent in the a phase or the B phase.
In some embodiments, the cationic polymer in the a phase, as a percentage of the mass of the a phase, that is different from the B phase, is 0.15-0.75%, specifically may be 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 0.40%, 0.45%, 0.50%, 0.55%, 0.60%, 0.65%, 0.70%, 0.75%, etc.
In some embodiments, the cationic polymer in the B phase, as a percentage of the mass of the B phase, that is different from the a phase, is 0.15-0.75%, specifically may be 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 0.40%, 0.45%, 0.50%, 0.55%, 0.60%, 0.65%, 0.70%, 0.75%, etc.
In some embodiments, the a-phase and/or B-phase may also contain other surfactants.
In the present application, the other surfactant refers to any other surfactant than the above surfactant, and for the other surfactant, it may be present in the a phase or the B phase, or both the a phase and the B phase, as long as at least one different surfactant is present in the a phase and the B phase.
In the phase a, the content of the surfactant (i.e., the total surfactant content) is not limited in any way, and may be conventionally selected as needed, for example, the content of the surfactant in the phase a may be 8% to 20%.
In phase B, the surfactant content (total surfactant content) may be 8% to 20%.
In some embodiments, the a-phase and/or B-phase may also include other conditioning agents including silicone oils and/or other cationic polymers. The presence or absence of the silicone oil does not affect the technical effect achieved by the composition of the present application. Further, in order to facilitate the user to distinguish between the different phases, silicone oil may be added to the a-phase or the B-phase, or silicone oil may be added to the a-phase and the B-phase in different amounts, so that the a-phase and the B-phase have different appearances, such as transparent, translucent or opaque appearances.
Silicone oils generally refer to linear silicone products that remain liquid at room temperature, and generally fall into two categories, methyl silicone oils and modified silicone oils. In the present application, there is no limitation in the specific type of silicone oil, which may be conventionally selected as required, and for example, the silicone oil may be cyclopentadimethicone, dimethicone, dimethiconol, amino terminal dimethicone, bis-aminopropyl dimethicone, phenyl dimethicone, or the like.
In the present application, the other cationic polymer refers to a cationic polymer other than the added cationic polymer, which may be present in the a phase or the B phase or in the a phase and the B phase.
In the present application, the content of the cationic polymer in the a phase and/or the B phase (i.e., the content of the total cationic polymer in the a phase or the B phase) is not subject to any limitation, and may be conventionally selected as required, for example, the content of the cationic polymer in the a phase may be 0.01% to 5%, and the content of the cationic polymer in the B phase may be 0.01% to 5%.
In the present application, the content of silicone oil in the phase is not limited at all, and it may be conventionally selected as required, for example, the content of silicone oil in the a phase or the B phase is 0.01% to 5%.
In some embodiments, the phase a and/or phase B may also contain adjuvants that may be used in the care product, such as: solvents, preservatives, oils, fragrances, pigments, dyes, rheology agents, thickening components and the like. As the thickening component, it may be a thickening component commonly used in the art, including a thickener, a salt. The thickening component serves to increase the viscosity of the composition, which increases the degree of surfactant micelle alignment. The thickening agent includes, but is not limited to, PEG-150 distearate, PEG-120 methylglucdioleate, xanthan gum, acrylic acid (esters) and C10-30 alkanol acrylate cross-linked polymer, acrylic acid (esters) copolymer and hydroxypropyl methylcellulose. Such salts include, but are not limited to, sodium chloride, potassium chloride, calcium chloride, and the like.
In the present application, the content of the thickener in the a phase and the B phase is not limited, and may be conventionally selected as required, and for example, the thickener may be 0.05 to 8%, specifically 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, 6.5%, 7%, 7.5%, 8%.
In the present application, the content of the salt in the a phase and the B phase is not limited in any way, and may be selected as desired in a conventional manner, and for example, the salt may be 0.5 to 5%, specifically 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%.
In some embodiments, the hair treatment composition further comprises an active ingredient acceptable on a toilet article. The active ingredient may be water-soluble active ingredient, such as hyaluronic acid or its salt, ectoin, fermentation filtrate, algae extract, anti-dandruff antibacterial agent such as Zinc Pyrithione (ZPT) or piroctone Olamine (OCT), hydrolyzed zein, hydrolyzed yeast protein, plankton extract, and lysine carboxymethyl cysteinate.
In some embodiments, the hair treatment composition comprises a phase a and a phase B, each comprising a surfactant and a cationic polymer, the phase a and B being non-mixed or non-homogeneously mixed two phases; the phase A and the phase B contain at least one different surfactant; the phase a and the phase B contain at least one different cationic polymer. In some embodiments the mass ratio between the different surfactants present in the a and B phases is from 3:1 to 1:3. For example, the mass ratio between the different surfactants present in the a and B phases may be 3:1, 2:1, 1:1, 1:2, 1:3, etc.
In some embodiments, the hair treatment composition comprises a phase a and a phase B, each comprising a surfactant and a cationic polymer, the phase a and B being non-mixed or non-homogeneously mixed two phases; the phase A and the phase B contain at least one different surfactant; the phase a and the phase B contain at least one different cationic polymer. In some embodiments, the mass ratio between the different surfactants present in the a-phase and the B-phase is from 3:1 to 1:3. For example, the mass ratio between the different surfactants present in the a and B phases may be 3:1, 2:1, 1:1, 1:2, 1:3, etc. In some embodiments, the mass ratio of the different cationic polymers present in the a phase and the B phase is from 3:2 to 1:2. For example, the mass ratio of the different cationic polymers present in the A and B phases may be 3:2, 1:0.8, 1:1, 1:1.5, 1:2, etc.
In some embodiments, the hair treatment composition comprises a phase a and a phase B, each comprising a surfactant and a cationic polymer, the phase a and B being non-mixed or non-homogeneously mixed two phases; the phase A and the phase B contain at least one different surfactant; the phase a and the phase B contain at least one different cationic polymer. In some embodiments, the mass ratio between the different surfactants present in the a-phase and the B-phase is from 3:1 to 1:3. For example, the mass ratio between the different surfactants present in the a and B phases may be 3:1, 2:1, 1:1, 1:2, 1:3, etc. In some embodiments, the mass ratio of the different cationic polymers present in the a phase and the B phase is from 3:2 to 1:2. For example, the mass ratio of the different cationic polymers present in the A and B phases may be 3:2, 1:0.8, 1:1, 1:1.5, 1:2, etc. In some embodiments, the surfactant in the a phase is 8-20% by mass of the a phase, specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, etc.; the surfactant in the B phase accounts for 8-20% by mass, and specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20% by mass, etc. In some embodiments, the surfactant content in the a phase or the B phase may be the same or different in terms of mass percent in the a phase or the B phase.
In some embodiments, the hair treatment composition comprises a phase a and a phase B, each comprising a surfactant and a cationic polymer, the phase a and B being non-mixed or non-homogeneously mixed two phases; the phase A and the phase B contain at least one different surfactant; the phase a and the phase B contain at least one different cationic polymer. In some embodiments, the mass ratio between the different surfactants present in the a-phase and the B-phase is from 3:1 to 1:3. For example, the mass ratio between the different surfactants present in the a and B phases may be 3:1, 2:1, 1:1, 1:2, 1:3, etc. In some embodiments, the mass ratio of the different cationic polymers present in the a phase and the B phase is from 3:2 to 1:2. For example, the mass ratio of the different cationic polymers present in the A and B phases may be 3:2, 1:0.8, 1:1, 1:1.5, 1:2, etc. In some embodiments, the surfactant in the a phase is 8-20% by mass of the a phase, specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, etc.; the surfactant in the B phase accounts for 8-20% by mass, and specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20% by mass, etc. In some embodiments, the surfactant content in the a phase or the B phase may be the same or different in terms of mass percent in the a phase or the B phase. In some embodiments, the cationic polymer in the a phase, as a percentage of the mass of the a phase, that is different from the B phase, is 0.15-0.75%, specifically may be 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 0.40%, 0.45%, 0.50%, 0.55%, 0.60%, 0.65%, 0.70%, 0.75%, etc. In some embodiments, the cationic polymer in the B phase, as a percentage of the mass of the B phase, that is different from the a phase, is 0.15-0.75%, specifically may be 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 0.40%, 0.45%, 0.50%, 0.55%, 0.60%, 0.65%, 0.70%, 0.75%, etc.
In some embodiments, the hair treatment composition comprises a phase a and a phase B, each comprising a surfactant and a cationic polymer, the phase a and B being non-mixed or non-homogeneously mixed two phases; the phase A and the phase B contain at least one different surfactant; the phase a and the phase B contain at least one different cationic polymer. In some embodiments, the mass ratio between the different surfactants present in the a-phase and the B-phase is from 3:1 to 1:3. For example, the mass ratio between the different surfactants present in the a and B phases may be 3:1, 2:1, 1:1, 1:2, 1:3, etc. In some embodiments, the mass ratio of the different cationic polymers present in the a phase and the B phase is from 3:2 to 1:2. For example, the mass ratio of the different cationic polymers present in the A and B phases may be 3:2, 1:0.8, 1:1, 1:1.5, 1:2, etc. In some embodiments, the surfactant in the a phase is 8-20% by mass of the a phase, specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, etc.; the surfactant in the B phase accounts for 8-20% by mass, and specifically may be 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20% by mass, etc. In some embodiments, the surfactant content in the a phase or the B phase may be the same or different in terms of mass percent in the a phase or the B phase. In some embodiments, the cationic polymer in the a phase, as a percentage of the mass of the a phase, that is different from the B phase, is 0.15-0.75%, specifically may be 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 0.40%, 0.45%, 0.50%, 0.55%, 0.60%, 0.65%, 0.70%, 0.75%, etc. In some embodiments, the cationic polymer in the B phase, as a percentage of the mass of the B phase, that is different from the a phase, is 0.15-0.75%, specifically may be 0.15%, 0.20%, 0.25%, 0.30%, 0.35%, 0.40%, 0.45%, 0.50%, 0.55%, 0.60%, 0.65%, 0.70%, 0.75%, etc. In some embodiments, the a-phase and/or B-phase may also contain other surfactants. In some embodiments, the a-phase and/or B-phase may also include other conditioning agents including silicone oils and/or other cationic polymers. In some embodiments, the phase a and/or phase B may also contain adjuvants that may be used in the care product. In some embodiments, the hair treatment composition further comprises an active ingredient acceptable on a toilet article.
The present application is not limited to the above-described hair treatment composition, but may be independent products each comprising a phase a composition and a phase B composition, as long as these independent products are used in combination at the time of use.
The application provides the use of a phase A composition and a phase B composition in combination in hair treatment, both of the phase A composition and the phase B composition containing a surfactant and a cationic polymer; the phase A composition and the phase B composition contain at least one different surfactant; the phase A composition and the phase B composition contain at least one different cationic polymer. In some embodiments, the phase a and phase B compositions are the phases a and B referred to above.
The hair treatment composition can effectively solve the problem of conditioning accumulation by regulating the deposition rate and the deposition degree of the cationic polymer.
The present application provides for the use of the hair treatment composition in cleaning and caring for hair.
In some embodiments, the use of the hair treatment composition to improve the deposition rate of conditioning agents on hair.
In some embodiments, the use of the hair treatment composition to improve hair shine and/or collapse.
The present application provides a method of using the hair treatment composition comprising:
applying phase a and phase B of the hair treatment composition to hair;
washing the phase a and phase B on the hair.
In the present application, the manner in which the a phase and the B phase are applied to the hair is not limited, and may be selected as desired, for example, when the a phase and the B phase are two phases which are not mixed, the application includes simultaneous application or sequential application, and the a phase and the B phase may be directly applied to a position required by a user, or the a phase and the B phase may be simply mixed (without being uniformly mixed) and then applied to a position required by a user, or the a phase may be applied to a position required by a user first, then the B phase may be applied to a position required by a user first, or the B phase may be applied to a position required by a user first, then the a phase may be applied to a position required by a user; when the A phase and the B phase are non-uniformly mixed two phases, the product can be directly applied to a position required by a user. Thereby solving the problem of "conditioning accumulation" at the desired location of the subject.
The present application provides the use of a phase a and B phase compositions, both containing a surfactant and a cationic polymer, in a hair treatment, the a and B phases being non-mixed or non-homogeneously mixed two phases;
the phase A and the phase B contain at least one different surfactant;
the phase a and the phase B contain at least one different cationic polymer.
In some embodiments, the phase a and phase B compositions are the phases a and B referred to above.
In the present application, the relation between the amounts of the a phase and the B phase is not limited, and may be selected according to needs, for example, the ratio of the amounts of the a phase and the B phase may be 7:3 to 3:7, specifically may be 7:3, 1:0.5, 1:1, 1:1.5, 1:2, 3:7, and the like.
Examples
The materials used in the test and the test methods are generally and/or specifically described herein, and in the examples which follow,% represents wt%, i.e., weight percent, unless otherwise specified. The reagents or apparatus used were conventional reagent products commercially available without the manufacturer's knowledge.
Examples 1 to 6, comparative examples 2 to 6
Preparation of phase A: the components shown in Table 1 were dissolved in water to give phase A.
Preparation of phase B: the components shown in Table 1 were dissolved in water to give phase B.
Wherein the content of each component in the A phase and the B phase is shown in Table 1.
Comparative example 1
The components shown in Table 1 were dissolved in water to obtain a mixed solution, and the contents of the respective components are shown in Table 1.
TABLE 1
Experimental example determination of deposition rate of Conditioning agent
Experiments to detect "conditioning accumulation" were performed using a bundle of genuine human hair (from the same individual). The deposition rate of the conditioner was calculated by measuring the mass increase of the hair tress through 2 and 6 wash cycles of the hair tress. A "conditioning balance" is considered to be achieved if the relative rate of change of the deposition rate of the conditioning agent after 2 washes and 6 washes does not exceed 5%. Wherein, the relative change rate of the conditioner deposition rate= (conditioner deposition rate for 6 times washing-conditioner deposition rate for 2 times washing)/conditioner deposition rate for 2 times washing.
The operation steps are as follows:
s1, hanging the hair bundle at normal temperature, drying by a normal temperature blower, standing the hair bundle at normal temperature for 24 hours, and balancing water with the environment;
s2, weighing and recording the mass of the dry hair comb;
s3, taking a 200ml plastic sampling bottle, putting all hair bundles into the bottle, and placing the bottle on a balance for zeroing; then, 2.0g (+/-0.1 g) of the samples prepared in the above examples and comparative examples, and 2.0g deionized water (DI water) were added to the flask, and the hair tress-sample-water was stirred with a glass rod for about 3 minutes, allowing all hair tress to be uniformly contacted with the shampoo;
s4, adding 100ml of DI water into a bottle, stirring for about 1 minute by using a glass rod, and pouring the liquid; adding 100m DI water into the bottle, stirring with a glass rod for about 1 minute, and pouring the liquid; adding 100m DI water into the bottle, stirring with a glass rod for about 1 minute, and pouring the liquid;
s5, taking out the starting beam by using tweezers and hanging the starting beam vertically.
For 2 wash cycles, the steps are: S1-S2 →S3→S4→S3→S4→S5→S1→S2;
For 6 wash cycles, the steps are: S1-S2 →S3→S4→S3→S4→S3
→S4→S3→S4→S3→S4→S3→S4Results of the measured deposition rate of the conditioner are shown in Table 2.
TABLE 2
The above description is only of the preferred embodiments of the present application and is not intended to limit the present application in any way, and any person skilled in the art may make modifications or alterations to the disclosed technical content to the equivalent embodiments. However, any simple modification, equivalent variation and variation of the above embodiments according to the technical substance of the present application still fall within the protection scope of the technical solution of the present application.
Claims (10)
1. A hair treatment composition comprising a phase a and a phase B, both containing a surfactant and a cationic polymer, the a and B phases being non-mixed or non-homogeneously mixed two phases;
the phase A and the phase B contain at least one different surfactant;
the phase a and the phase B contain at least one different cationic polymer.
2. The hair treatment composition according to claim 1, wherein the mass ratio between the different surfactants present in the a-phase and B-phase is from 3:1 to 1:3.
3. The hair treatment composition according to claim 1 or 2, wherein the mass ratio of the different cationic polymers present in the a-phase and B-phase is from 3:2 to 1:2.
4. The hair treatment composition according to any one of claims 1 to 3, wherein,
the mass percentage of the surfactant in the phase A is 8-20%;
the mass percentage of the surfactant in the phase B is 8-20%.
5. The hair treatment composition according to any one of claims 1 to 4, wherein,
the cationic polymer in the A phase is 0.15-0.75% of the cationic polymer in the B phase;
the cationic polymer in the B phase is 0.15-0.75% of the cationic polymer in the A phase.
6. Use of the hair treatment composition according to any one of claims 1 to 5 for cleaning and caring hair.
7. The use according to claim 6, wherein the hair treatment composition is used to improve the deposition rate of conditioning agents on hair;
preferably, the use of the hair treatment composition for improving hair shine and/or collapse.
8. A method of using the hair treatment composition of any of claims 1-5, comprising:
applying phase a and phase B of said hair treatment composition to hair;
washing the phase a and phase B on the hair.
9.A phase composition and phase B composition, both of which contain a surfactant and a cationic polymer, are used in combination in hair treatment;
the phase A composition and the phase B composition contain at least one different surfactant;
the phase A composition and the phase B composition contain at least one different cationic polymer.
10. Use according to claim 9, wherein the a-phase and B-phase compositions are those according to any one of claims 2 to 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310184387.XA CN116139042A (en) | 2023-02-24 | 2023-02-24 | Hair treatment composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310184387.XA CN116139042A (en) | 2023-02-24 | 2023-02-24 | Hair treatment composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116139042A true CN116139042A (en) | 2023-05-23 |
Family
ID=86356192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310184387.XA Pending CN116139042A (en) | 2023-02-24 | 2023-02-24 | Hair treatment composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116139042A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1222073A (en) * | 1996-04-15 | 1999-07-07 | 斯蒂潘公司 | Cleaning, conditioning and styling hair care compsns. |
US5980877A (en) * | 1996-10-25 | 1999-11-09 | The Procter & Gamble Company | Conditioning shampoo composition |
CN107530239A (en) * | 2015-04-23 | 2018-01-02 | 宝洁公司 | Use the Hair Treatment Protocol of aerosol foam concentrated type conditioner |
CN109512703A (en) * | 2018-12-29 | 2019-03-26 | 拉芳家化股份有限公司 | A kind of hair is first supported washes product systems afterwards |
CN110354021A (en) * | 2018-03-26 | 2019-10-22 | 赫尔克里士有限公司 | Application of the cationic polymer in pre-shampoo conditioning composition |
CN114728183A (en) * | 2019-08-30 | 2022-07-08 | 宝洁公司 | Hair conditioning product comprising a first composition and a second composition |
-
2023
- 2023-02-24 CN CN202310184387.XA patent/CN116139042A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1222073A (en) * | 1996-04-15 | 1999-07-07 | 斯蒂潘公司 | Cleaning, conditioning and styling hair care compsns. |
US5980877A (en) * | 1996-10-25 | 1999-11-09 | The Procter & Gamble Company | Conditioning shampoo composition |
CN107530239A (en) * | 2015-04-23 | 2018-01-02 | 宝洁公司 | Use the Hair Treatment Protocol of aerosol foam concentrated type conditioner |
CN110354021A (en) * | 2018-03-26 | 2019-10-22 | 赫尔克里士有限公司 | Application of the cationic polymer in pre-shampoo conditioning composition |
CN109512703A (en) * | 2018-12-29 | 2019-03-26 | 拉芳家化股份有限公司 | A kind of hair is first supported washes product systems afterwards |
CN114728183A (en) * | 2019-08-30 | 2022-07-08 | 宝洁公司 | Hair conditioning product comprising a first composition and a second composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102041898B1 (en) | Conditioning composition additive for providing immediate and long lasting benefits to keratin substrates | |
RU2226384C1 (en) | Cosmetic compositions containing aminated silicone and thickening agent and methods for their application | |
US7012048B2 (en) | Composition and method for treating hair containing a cationic ampholytic polymer and an anionic benefit agent | |
US11166894B2 (en) | Shampoo compositions comprising a chelant | |
CN101039654B (en) | Hair care formulations comprising aminofunctional polyoganosiloxane | |
RU2002129810A (en) | COSMETIC COMPOSITIONS CONTAINING AMINOSILICONE AND THICKENING AGENT, AND THEIR APPLICATION | |
WO1997038673A9 (en) | Cleaning, conditioning and styling hair care compositions | |
EP2403472A2 (en) | Ampholytic ter-polymers for use in personal care compositions | |
US11246816B2 (en) | Shampoo compositions comprising a chelant | |
KR20080039837A (en) | Copolymer and detergent compositions containing the same | |
BR112019010685B1 (en) | COSMETIC COMPOSITION COMPRISING A CATIONIC COPOLYMER, ITS USE, PROCESS OF FORMULATION THE SAME AND METHOD FOR USE OF THE COSMETIC COMPOSITION | |
CN102300553A (en) | Cosmetic composition and hair wash | |
RU2213555C2 (en) | Composition for taking care for hair | |
CN116139042A (en) | Hair treatment composition | |
US4831097A (en) | Heterocyclic containing cellulosic graft polymers | |
CN103845231A (en) | Shampoo conditioning composition containing PPG-3 octyl ether | |
WO1998030196A1 (en) | Homopolymers prepared from ammonium quaternary salts of aminoalkylacrylamides | |
US11376209B2 (en) | Antidandruff composition and method of use | |
US20230346668A1 (en) | Hair treatment composition | |
WO2023060175A1 (en) | Sulfate free shampoo composition containing a cationic polymer and inorganic salt | |
WO2021104811A1 (en) | Method for determining rinse properties | |
JPH02115113A (en) | Treatment composition | |
WO2013048780A1 (en) | Cationic conditioner replacements | |
BR112020006415B1 (en) | AQUEOUS ANTI-DANDRUFF SHAMPOO COMPOSITION AND USE OF A COMPOSITION | |
JPH04134021A (en) | Hair rinse composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |